Mastek’s stock is trading at Rs. 2845.80, an increase of 5.05 points or 0.18% from its last close of Rs. 2840.75 on the BSE.

The stock began at Rs. 2851.05, reaching a high of Rs. 2894.80 and a low of Rs. 2820.00 during the session, with 1643 shares changing hands.

Mastek, classified under the BSE ‘A’ group with a face value of Rs. 5, achieved a 52-week high of Rs. 3147.00 on February 16, 2024, and a 52-week low of Rs. 2105.95 on October 26, 2023. Over the last week, the stock fluctuated between Rs. 3058.00 and Rs. 2820.00. The company’s market capitalization is Rs. 8770.18 crore.

Promoters hold a 36.23% stake in the company, with institutions and non-institutions owning 18.54% and 45.22%, respectively.

Mastek has forged a strategic alliance with Innovaccer, a top healthcare AI company, to enhance healthcare results, lower costs, and meet performance benchmarks. This partnership aims to strengthen Mastek’s healthcare segment by leveraging Innovaccer’s expertise in data integration, AI, and analytics to improve its services and support value-based care initiatives.

Through this collaboration, Mastek and Innovaccer will offer comprehensive solutions to healthcare providers, improving patient outcomes, care quality, and affordability.

Innovaccer’s AI-driven Health Experience Platform (HXP) consolidates data from various sources such as electronic health records (EHRs), customer relationship management (CRM) systems, and enterprise data warehouses (EDWs). By incorporating this platform into Mastek’s Healthcloud, healthcare providers can access predictive insights, helping to improve decisions and patient care.

Mastek, along with its subsidiaries, delivers enterprise technology solutions across insurance, government, and financial services sectors globally.